Executive functions disorders in children with dyslexia
Chutko LS, Surushkina SY, Yakovenko EA, I Anisimova T, Didur MD, Chekalova SA · 2021 · Zh Nevrol Psikhiatr Im S S Korsakova 121(2):38-45. PMID 33728849
What does this source report?
Thirty treated patients received Cortexin and thirty encephabol; reading, attention and memory changes were reported.
- Population and setting
- 60 children with dyslexia; 60 healthy reference children
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Healthy reference children are not an untreated dyslexia control; no established masking.
- Pediatric clinical findings do not establish enhancement or safety in healthy adults.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Chutko LS, Surushkina SY, Yakovenko EA, I Anisimova T, Didur MD, Chekalova SA. Executive functions disorders in children with dyslexia Zh Nevrol Psikhiatr Im S S Korsakova 121(2):38-45. PMID 33728849 2021.
Molekul research summary: https://molekul.io/research/bio-33728849. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry